Hodgkin-limfóma: vizsgálatok itt: Egyesült Államok
76 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peoplePhase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Where
- Basking Ridge, Commack, Duarte, Harrison, Miami, Middletown, Montvale, New York, Stanford, Uniondale
- Életkor
- 18 év and over
- People
- 257
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03618550 - No phaseTaking peoplePatient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Where
- Aurora, Boston, Hackensack, Memphis, New York, Palo Alto, Rochester
- Életkor
- 8 év and over
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT06098430 - 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Albany, Anchorage, Aurora, Baton Rouge, Boise, Boston, Chattanooga, Clovis, East Syracuse, Eugene, Fairfax, Fullerton, Gainesville, Glendale, Grand Rapids, Lexington, Los Angeles, Miami, Nashville, Omaha, Orlando, Panorama City, Portland, San Francisco, Swansea, Tacoma, Temple, The Woodlands, Torrance, Tyler, Virginia Beach, Waukee
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Cleveland, Denver, Los Angeles, Nashville
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - No phaseTaking peopleBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Where
- Bethesda
- Életkor
- 18 év to 120 év
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02682667 - 2. fázisTaking peopleAuto Stem Cell Transplant for Lymphoma Patients
- Where
- Minneapolis
- Életkor
- Up to 75 év
- People
- 150
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03125642 - 1. fázisTaking peopleA Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Where
- Athens, Birmingham, Boston, Buffalo, Fort Wayne, Margate, Nashville, Orlando, Palo Alto, Sarasota, Spokane
- Életkor
- 18 év and over
- People
- 85
- Run by
- Compass Therapeutics
See details and how to joinNCT06150664 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Atlanta, Boston, Columbus, Dallas, Denver, Duarte, Houston, Los Angeles, Miami, Milwaukee, Nashville, New York, Portland, Rochester, San Francisco, Sarasota, Scottsdale, Seattle
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 2. fázisTaking peoplePersonalized NK Cell Therapy in CBT
- Where
- Houston
- Életkor
- 15 év to 80 év
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02727803 - 1/2. fázisTaking peopleNivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
- Where
- Chicago, Columbus, Indianapolis, Iowa City, Madison, Minneapolis
- Életkor
- 18 év and over
- People
- 54
- Run by
- Veronika Bachanova
See details and how to joinNCT03681561 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Charlotte, Los Angeles, Louisville, Milwaukee, Richmond, Spokane
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - No phaseTaking peoplePharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Where
- Atlanta, Aurora, Cincinnati, Houston, Milwaukee, Philadelphia
- Életkor
- 0 év to 38 év
- People
- 30
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06131801 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Életkor
- 18 év to 120 év
- People
- 15 000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - 1. fázisTaking peopleAlpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- Where
- Madison
- Életkor
- 7 hónap to 21 év
- People
- 22
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT02508038 - No phaseTaking peopleTissue Collection for Studies of Lymph Cancer
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 1295 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01676805 - 2. fázisTaking peopleAlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Where
- Valhalla
- Életkor
- 1 nap to 30 év
- People
- 20
- Run by
- Mitchell Cairo
See details and how to joinNCT04099966 - 2. fázisTaking peopleCMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Életkor
- 18 év to 75 év
- People
- 216
- Run by
- City of Hope Medical Center
See details and how to joinNCT06059391 - 1. fázisTaking peopleA Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Where
- Atlanta, Boston, Duarte
- Életkor
- 18 év to 75 év
- People
- 46
- Run by
- City of Hope Medical Center
See details and how to joinNCT07020533 - No phaseCsak meghívásosBiology Studies of Hematologic Cancers
- Where
- Bethesda
- Életkor
- 1 év to 120 év
- People
- 550
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923442 - 3. fázisTaking peopleWisconsin Ginseng for Decreasing Cancer Related Fatigue
- Where
- Albert Lea, Bemidji, Brainerd, Deer River, Detroit Lakes, Duluth, Fosston, Hibbing, Mankato, Monticello, Rochester, Sandstone, Thief River Falls, Virginia, Worthington
- Életkor
- 18 év and over
- People
- 222
- Run by
- Mayo Clinic
See details and how to joinNCT06395441 - 2. fázisTaking peoplectDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- Where
- Davis, Fresno, Irvine, La Jolla, Los Angeles, San Francisco
- Életkor
- 18 év and over
- People
- 38
- Run by
- Michael Spinner, MD
See details and how to joinNCT07021989 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Austin, Charlotte, Chicago, Columbus, Duarte, Houston, Iowa City, Jacksonville, Milwaukee, Nashville, New Brunswick, New York, Overland Park, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, San Antonio, St Louis, Tampa, Waukee
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - No phaseTaking peopleEstablishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
- Where
- Boston
- Életkor
- 18 év and over
- People
- 1500
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT00131014 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Atlanta, Boston, Duarte, Houston, Miami, New York, Philadelphia
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 1. fázisTaking peopleA Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Where
- Aurora, Chicago, Cincinnati, Los Angeles, Palo Alto, Philadelphia, Salt Lake City, San Antonio, Seattle
- Életkor
- 0 év to 18 év
- People
- 30 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00